Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma.

Détails

Ressource 1Télécharger: BIB_12A813318318.P001.pdf (161.54 [Ko])
Etat: Serval
Version: de l'auteur
ID Serval
serval:BIB_12A813318318
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma.
Périodique
EJNMMI Research
Auteur(s)
Buchegger F., Press O.W.
ISSN
2191-219X (Electronic)
Statut éditorial
Publié
Date de publication
2011
Volume
1
Numéro
1
Pages
7
Langue
anglais
Notes
Publication types: Journal ArticlePublication Status: epublish
Résumé
ABSTRACT: Several reports have documented similar efficacies and tolerable toxicities of radioimmunotherapy (RIT) consolidation and rituximab maintenance after initial R-chemotherapy of follicular lymphoma. The relative merits of these two interventions are currently under discussion. We now raise the question whether both RIT consolidation and rituximab maintenance should be used together aiming to augment the results achievable with R-chemotherapy.
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/03/2012 18:46
Dernière modification de la notice
08/05/2019 14:43
Données d'usage